{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:50:18Z","timestamp":1791424218036,"version":"4.3.3"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.drudis.2026.104818","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:19:34Z","timestamp":1790608774000},"page":"104818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paradigm shift in the management of drug development projects: artificial-intelligence-enabled parallel scenario execution for managing uncertainty"],"prefix":"10.1016","volume":"31","author":[{"given":"Shinichi","family":"Tsuchiwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-2947","authenticated-orcid":false,"given":"Yasuhiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104818_b0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/qje\/qjae044","article-title":"Generative AI at work","volume":"140","author":"Brynjolfsson","year":"2025","journal-title":"Q J Econ"},{"key":"10.1016\/j.drudis.2026.104818_b0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/ph19040614","article-title":"Generative artificial intelligence transitions pharmaceutical development from empirical screening to predictive molecular design and clinical trial optimization","volume":"19","author":"Mansour","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2026.104818_b0015","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/psp4.12944","article-title":"Computational design of clinical trials using a combination of simulation and the genetic algorithm","volume":"12","author":"Tsuchiwata","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.drudis.2026.104818_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10462-025-11471-9","article-title":"From language to action: a review of large language models as autonomous agents and tool users","volume":"59","author":"Chowa","year":"2026","journal-title":"Artif Intell Rev"},{"key":"10.1016\/j.drudis.2026.104818_b0025","article-title":"From LLM reasoning to autonomous AI agents: a comprehensive review","author":"Ferrag","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104818_b0030","first-page":"67","article-title":"Toyota\u2019s principles of set-based concurrent engineering","volume":"40","author":"Sobek","year":"1999","journal-title":"Sloan Manage Rev"},{"key":"10.1016\/j.drudis.2026.104818_b0035","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/dsj.2020.16","article-title":"Set-based design: a review and new directions","volume":"6","author":"Toche","year":"2020","journal-title":"Des Sci"},{"key":"10.1016\/j.drudis.2026.104818_b0040","doi-asserted-by":"crossref","first-page":"33666","DOI":"10.1038\/s41598-025-18181-w","article-title":"A hybrid innovation method based on quality by design and agile scrum paradigms for the development of medicinal products","volume":"15","author":"Bastogne","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104818_b0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/psp4.12071","article-title":"A six-stage workflow for robust application of systems pharmacology","volume":"5","author":"Gadkar","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.drudis.2026.104818_b0050","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/psp4.12426","article-title":"Quantitative systems pharmacology: an exemplar model-building workflow with applications in cardiovascular, metabolic, and oncology drug development","volume":"8","author":"Helmlinger","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.drudis.2026.104818_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70547","article-title":"From models to medicines: a narrative history and regulatory perspective on the translational impact of model-informed drug development (MIDD)","volume":"19","author":"Zineh","year":"2026","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.drudis.2026.104818_b0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cpt.3636","article-title":"Impact of model-informed drug development on drug development cycle times and clinical trial cost","volume":"118","author":"Sahasrabudhe","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.drudis.2026.104818_b0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/info16080682","article-title":"Artificial intelligence in project success: a systematic literature review","volume":"16","author":"Su","year":"2025","journal-title":"Information"},{"key":"10.1016\/j.drudis.2026.104818_b0070","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s11301-024-00418-z","article-title":"How artificial intelligence will transform project management in the age of digitization: a systematic literature review","volume":"75","author":"Nenni","year":"2025","journal-title":"Manag Rev Q"},{"key":"10.1016\/j.drudis.2026.104818_b0075","first-page":"1","article-title":"A survey on hallucination in large language models: principles, taxonomy, challenges, and open questions","volume":"43","author":"Huang","year":"2025","journal-title":"ACM Trans Inf Syst"},{"key":"10.1016\/j.drudis.2026.104818_b0080","unstructured":"U.S. Food and Drug Administration. Using artificial intelligence & machine learning in the development of drug & biological products: discussion paper and request for feedback. www.fda.gov\/media\/167973\/download. Published May 10, 2023. Updated February 18, 2025. Accessed September 14, 2026."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:55:08Z","timestamp":1791420908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1359644626002230"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104818","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradigm shift in the management of drug development projects: artificial-intelligence-enabled parallel scenario execution for managing uncertainty","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104818"}}